Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study.
Satoshi YokoyamaChihiro NakagawaKouichi HosomiPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
Real-world data demonstrated that the administration rate of CIPN medication was higher in patients who received oxaliplatin treatment for over 6 months.